Selective PPAR modulators (SPPARs) may fill the need for treatment of the atherogenic dyslipidemia of insulin resistance and type 2 diabetes: Can they reduce the associated cardiac risk?

被引：2
作者：
Camejo, German [1 ]
机构：
[1] Lakegatan 22, S-42658 Gothenburg, Vastra Frolunda, Sweden
来源：
ATHEROSCLEROSIS | 2016年 / 249卷
关键词：
PPAR agonists; Selective PPAR alpha modulators (SPPARM alpha); Fibrates; Dyslipidemia; Reverse cholesterol transport; Inflammation; Mouse models; Atherosclerosis; AGONISTS; ALPHA;
D O I：
10.1016/j.atherosclerosis.2016.03.026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：224 / 225
页数：2
相关论文
共 7 条
  • [1] Metabolic and functional relevance of HDL subspecies
    Asztalos, Bela F.
    Tani, Mariko
    Schaefer, Ernst J.
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2011, 22 (03) : 176 - 185
  • [2] Selective peroxisome proliferator-activated receptora modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Fruchart, Jean-Charles
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [3] Early investigational drugs targeting PPAR-α for the treatment of metabolic disease
    Liu, Zhong-Min
    Hu, Miao
    Chan, Paul
    Tomlinson, Brian
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (05) : 611 - 621
  • [4] HDL2 interferes with LDL association with arterial proteoglycans: A possible athero-protective effect
    Umaerus, Mia
    Rosengren, Birgitta
    Fagerberg, Bjorn
    Hurt-Camejo, Eva
    Camejo, German
    [J]. ATHEROSCLEROSIS, 2012, 225 (01) : 115 - 120
  • [5] Pathophysiology of diabetic dyslipidaemia: where are we?
    Verges, Bruno
    [J]. DIABETOLOGIA, 2015, 58 (05) : 886 - 899
  • [6] THE RESPONSE-TO-RETENTION HYPOTHESIS OF EARLY ATHEROGENESIS
    WILLIAMS, KJ
    TABAS, I
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) : 551 - 561
  • [7] Minireview: Challenges and Opportunities in Development of PPAR Agonists
    Wright, Matthew B.
    Bortolini, Michele
    Tadayyon, Moh
    Bopst, Martin
    [J]. MOLECULAR ENDOCRINOLOGY, 2014, 28 (11) : 1756 - 1768
1